Literature DB >> 19494017

Cardif-mediated signaling controls the initial innate response to dengue virus in vivo.

Stuart T Perry1, Tyler R Prestwood, Steven M Lada, Chris A Benedict, Sujan Shresta.   

Abstract

The role of Cardif-dependent signaling in controlling dengue virus (DENV) infection and regulating type I interferon (IFN) production in vivo was examined in Cardif-deficient mice. DENV RNA levels were significantly elevated in both the serum and lymphoid tissues of Cardif(-/-) mice at early times compared to those in wild-type animals. Type I IFN production was delayed in these locales of Cardif(-/-) mice until 18 h postinfection, indicating that Cardif regulates the initial type I IFN response in lymphoid tissues. In contrast, DENV viral loads in nonlymphoid tissues were similar between Cardif(-/-) and wild-type mice. These results reveal that RNA helicase-mediated sensing acts as a first line of innate defense against DENV infection in vivo and functions in a tissue-dependent manner.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19494017      PMCID： PMC2715757          DOI： 10.1128/JVI.00365-09

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  25 in total

1.  Production of interferon alpha by dengue virus-infected human monocytes.

Authors:  I Kurane; F A Ennis
Journal:  J Gen Virol       Date:  1988-02       Impact factor: 3.891

2.  Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2.

Authors:  Tadaatsu Imaizumi; Satoko Aratani; Toshihiro Nakajima; Mary Carlson; Tomoh Matsumiya; Kunikazu Tanji; Keizou Ookawa; Hidemi Yoshida; Shigeki Tsuchida; Thomas M McIntyre; Stephen M Prescott; Guy A Zimmerman; Kei Satoh
Journal:  Biochem Biophys Res Commun       Date:  2002-03-22       Impact factor: 3.575

3.  Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization.

Authors:  Kala Jessie; Mun Yik Fong; Shamala Devi; Sai Kit Lam; K Thong Wong
Journal:  J Infect Dis       Date:  2004-04-05       Impact factor: 5.226

4.  New mouse model for dengue virus vaccine testing.

Authors:  A J Johnson; J T Roehrig
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  High levels of interferon alpha in the sera of children with dengue virus infection.

Authors:  I Kurane; B L Innis; S Nimmannitya; A Nisalak; A Meager; F A Ennis
Journal:  Am J Trop Med Hyg       Date:  1993-02       Impact factor: 2.345

6.  TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function.

Authors:  Anne Krug; Anthony R French; Winfried Barchet; Jens A A Fischer; Andrzej Dzionek; Jeanette T Pingel; Michael M Orihuela; Shizuo Akira; Wayne M Yokoyama; Marco Colonna
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

7.  Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.

Authors:  Sujan Shresta; Jennifer L Kyle; Heidi M Snider; Manasa Basavapatna; P Robert Beatty; Eva Harris
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.

Authors:  Koichi Tabeta; Philippe Georgel; Edith Janssen; Xin Du; Kasper Hoebe; Karine Crozat; Suzanne Mudd; Louis Shamel; Sosathya Sovath; Jason Goode; Lena Alexopoulou; Richard A Flavell; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

9.  A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity.

Authors:  Sathit Pichyangkul; Timothy P Endy; Siripen Kalayanarooj; Ananda Nisalak; Kosol Yongvanitchit; Sharone Green; Alan L Rothman; Francis A Ennis; Daniel H Libraty
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 10.  Dengue and dengue hemorrhagic fever.

Authors:  D J Gubler
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132
View more
  39 in total

1.  Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Authors:  Dong Jiang; Jessica M Weidner; Min Qing; Xiao-Ben Pan; Haitao Guo; Chunxiao Xu; Xianchao Zhang; Alex Birk; Jinhong Chang; Pei-Yong Shi; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

Review 3.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

4.  Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor.

Authors:  Susana Orozco; Michael A Schmid; Poornima Parameswaran; Ruben Lachica; Matthew R Henn; Robert Beatty; Eva Harris
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

5.  Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design.

Authors:  Daniela Weiskopf; Lauren E Yauch; Michael A Angelo; Daisy V John; Jason A Greenbaum; John Sidney; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Howard Grey; Bjoern Peters; Sujan Shresta; Alessandro Sette
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

6.  Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice.

Authors:  Tyler R Prestwood; Malika M Morar; Raphaël M Zellweger; Robyn Miller; Monica M May; Lauren E Yauch; Steven M Lada; Sujan Shresta
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

7.  The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus.

Authors:  Hui-Wen Chen; Kevin King; Jui Tu; Marisa Sanchez; Andrew D Luster; Sujan Shresta
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

8.  Dengue Virus Evolution under a Host-Targeted Antiviral.

Authors:  Emily Plummer; Michael D Buck; Marisa Sanchez; Jason A Greenbaum; Julia Turner; Rajvir Grewal; Brennan Klose; Aruna Sampath; Kelly L Warfield; Bjoern Peters; Urban Ramstedt; Sujan Shresta
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.

Authors:  Daniela Weiskopf; Michael A Angelo; John Sidney; Bjoern Peters; Sujan Shresta; Alessandro Sette
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

10.  Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.

Authors:  Zhenjian He; Xun Zhu; Weitao Wen; Jie Yuan; Yiwen Hu; Jiahui Chen; Shu An; Xinhuai Dong; Cuiji Lin; Jianchen Yu; Jueheng Wu; Yi Yang; Junchao Cai; Jun Li; Mengfeng Li
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.